Meet the AOECS Board of Directors
AOECS is pleased to introduce its Board of Directors following the General Assembly held in Amsterdam on 10 October 2026.
AOECS is pleased to introduce its Board of Directors following the General Assembly held in Amsterdam on 10 October 2026.
Around 130 delegates from across the world gathered in Amsterdam for the 38th AOECS Annual Conference to explore the future of coeliac health by 2030. Discussions focused on earlier diagnosis, more consistent care, emerging treatments and research that reflects patients’ priorities, with international cooperation central to turning progress into better everyday lives.
AOECS has joined United European Gastroenterology’s (UEG) new Patient Representatives Advisory Board, bringing the perspectives of people living with coeliac disease into a broader European dialogue on digestive health. The initiative aims to strengthen cooperation between patient organisations and medical professionals, ensuring that patients’ experiences and needs are better understood.
Abigail Zalba, General Coordinator of Coeliac Youth of Europe, will represent young people with coeliac disease at the first-ever EPF Youth Congress 2026 in Brussels, advocating for their rights and a stronger voice in European health policy. AOECS welcomes this opportunity for its youth network to engage in European patient advocacy.
Swedish researcher Elin Hård af Segerstad received the first AOECS Young Researcher Award, presented at its 38th Annual Conference in Amsterdam. Selected from six entries, she researches how to make life with coeliac disease easier. The award combines scientific assessment with patient perspectives to encourage research that makes a difference.
The 38th AOECS Annual Conference opens on 9 October, 2026 in Amsterdam, bringing together patient organisations, researchers and industry representatives to strengthen international cooperation, share scientific advances and shape the future of coeliac care.
The Association of European Coeliac Societies (AOECS) welcomes the new Codex Guidelines on Precautionary Allergen Labelling (PAL), a landmark step towards more consistent, science-based gluten risk communication. The Guidelines strengthen consumer confidence, improve international harmonisation and recognise, for the first time, the needs of people living with coeliac disease.